Gendreau R Michael

Avg. Two Year Performance

No purchase track record
25% Avg. Sale Return
12% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return0%0%0%0%0%
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return(11%)8%(17%)32%25%
Sale Success Rate0 of 22 of 21 of 21 of 22 of 2

Cypress Bioscience, Inc.

Drugs » Biotechnology

Chief Medical Officer:

Holdings: 114.25K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Intec Pharma Ltd.

Other » Other

Chief Medical Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--